Back to the overview page

Ivan (I) Peyron

Department
Plasma Proteins
E-mail
i.peyron@sanquin.nl
LinkedIn
https://fr.linkedin.com/pub/ivan-peyron/99/a97/aa3
Training

Immunology

Thesis

Research interests
Anti-factor VIII immune response, antigen presentation
Resume
2015-present Postdoctoral Fellow at the Dept of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands
2011-2013 PhD student at Institut National de la Santé et de la Recherche Médicale, UMR S 1138, Centre de Recherche des Cordeliers, Paris, France
2009-2011 MSc Systems and Signalization Integrated in Biology, École Pratique des Hautes Études, Paris, France
2008-2011 Bachelor in Analytical Biology, École Supérieure des Techniques de Biologie Apliquée, Paris, France
Publications
Sanquin publications
Other publications

Peyron I, Dimitrov JD, Delignat S, Gangadharan B, Planchais C, Kaveri SV, Lacroix-Desmazes S. Haemarthrosis and arthropathy do not favour the development of factor VIII inhibitors in severe haemophilia A mice. Haemophilia 2015; 21(1):e94-8.

Mahendra A, Peyron I, Dollinger C, Gilardin L, Sharma M, Wootla B, Padiolleau-Lefevre S, Friboulet A, Boquet D, Legendre C, Kaveri SV, Thaunat O, Lacroix-Desmazes S. IVIg treatment reduces catalytic antibody titers of renal transplanted patients. PLoS One 2013; 8(8):e70731.

Repessé Y*, Peyron I*, Dimitrov JD, Dasgupta S, Moshai EF, Costa C, Borel-Derlon A, Guillet B, D'Oiron R, Aouba A, Rothschild C, Oldenburg J, Pavlova A, Kaveri SV, Lacroix-Desmazes S; ABIRISK consortium. Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter. Haematologica 2013; 98(10):1650-5.

Repessé Y*, Dimitrov JD*, Peyron I, Farrokhi Moshai E, Kiger L, Dasgupta S, Delignat S, Marden MC, Kaveri SV, Lacroix-Desmazes S. Heme binds to factor VIII and inhibits its interaction with activated factor IX. J Thromb Haemost. 2012; 10(6):1062-71.

Last edited on: 21 April 2016
Back to the overview page